GREGORY B. BROWN, M.D. - Corporate Board Profile

LISATA THERAPEUTICS, INC.

Filing Date	Source Excerpt
2018-04-24	Gregory B. Brown, M.D. was appointed to the Caladrius Board in October 2016 and was elected Chairman by the Caladrius Board on February 16, 2017. ... The Audit Committee consists of three directors: Dr. Brown (Chairman), and Messrs. Klosk and Myers. ... Our Compensation Committee consists of four directors: Mr. Klosk (Chairman), Dr. Brown, Mr. Myers and Dr. Traber. ... Our Nominating and Governance Committee consists of three directors: Mr. Myers (Chairman), Dr. Brown and Dr. Traber. ... Science and Technology Committee: The Science and Technology Committee consists of Drs. Traber (Chairman), Brown, Mazzo and Mr. Klosk. ... The following table sets forth information on all compensation to Caladrius' directors (other than as reflected in the Summary Compensation Table) for the year ended December 31, 2017. ... Gregory B. Brown, M.D. $93,166 cash fees, $19,615 stock awards, $6,380 option awards, total $119,161.
2019-04-30	Gregory B. Brown, M.D. was appointed to the Caladrius Board in October 2016 and was elected Chairman by the Caladrius Board on February 16, 2017. The Audit Committee consists of four directors: Dr. Brown (Chairman), Messrs. Klosk and Myers and Ms. Schwalm. The Compensation Committee consists of four directors: Mr. Klosk (Chairman), Dr. Brown, Mr. Myers and Dr. Traber. Our Nominating and Governance Committee consists of three directors: Mr. Myers (Chairman), Dr. Brown and Dr. Traber. The Science and Technology Committee consists of Drs. Traber (Chairman), Brown, Mazzo and Mr. Klosk and Ms. Schwalm. The following table sets forth information on all compensation to Caladrius' directors for the year ended December 31, 2018. Gregory B. Brown, M.D.: Fees Earned in Cash $103,000, Stock Awards $33,151, Total Compensation $144,902.
2020-04-29	Dr. Brown was appointed to the Caladrius Board in October 2016 and was elected Chairman by the Caladrius Board on February 16, 2017. The Audit Committee consists of four directors: Dr. Brown (Chairman), Messrs. Klosk and Myers and Ms. Schwalm. The Compensation Committee consists of four directors: Mr. Klosk (Chairman), Dr. Brown, Mr. Myers and Dr. Traber. The Nominating and Governance Committee consists of three directors: Mr. Myers (Chairman), Dr. Brown and Dr. Traber. The Science and Technology Committee consists of Drs. Traber (Chairman), Brown, Mazzo, Mr. Klosk and Ms. Schwalm. The following table sets forth information on all compensation to Caladrius' directors (other than as reflected in the Summary Compensation Table) for the year ended December 31, 2019. Gregory B. Brown, M.D.: Fees Earned or Paid in Cash $103,000; Stock Awards $59,999; Total Compensation $162,999.
2021-04-28	Gregory B. Brown, M.D. was appointed to the Caladrius Board in October 2016 and was elected Chairman by the Caladrius Board on February 16, 2017. ... The Audit Committee consists of four directors: Dr. Brown (Chairman), Messrs. Klosk and Myers and Ms. Schwalm. ... The following table sets forth information on all compensation to Caladrius' directors (other than as reflected in the Summary Compensation Table) for the year ended December 31, 2020. ... Gregory B. Brown, M.D. (2) $101,875 Fees Earned in Cash, $59,998 Stock Awards, $0 Option Awards, $161,873 Total Compensation.
2023-05-01	Gregory B. Brown, M.D. was appointed to the Board in October 2016 and was elected Chairman by our Board on February 16, 2017. ... The Audit Committee consists of three directors: Ms. Henson (Chair), Ms. Flowers and Mr. Klosk. ... Our Compensation Committee consists of three directors: Mr. Klosk (Chair), Dr. Brown and Ms. Henson. ... Our Nominating and Governance Committee consists of four directors: Dr. Gregory Brown (Chair), Dr. Azab, Ms. Flowers and Dr. Ruoslahti. ... The following table sets forth information on all compensation to Lisata's directors (other than as reflected in the Summary Compensation Table) for the year ended December 31, 2022. ... Gregory B. Brown, M.D. $95,858 Fees Earned in Cash, $59,999 Stock Awards, $155,857 Total Compensation.
2024-04-29	Gregory B. Brown, M.D. was appointed to our board of directors in October 2016 and was elected Chairman by our board of directors on February 16, 2017. Dr. Brown is currently Chief Executive Officer of Memgen, Inc., a development-stage biotechnology company.